BIIB021 Uses, Dosage, Side Effects and more
BIIB021 has been investigated for the treatment of Tumors and Lymphoma.
| Trade Name | BIIB021 |
| Generic | BIIB021 |
| Type | |
| Formula | C14H15ClN6O |
| Weight | Average: 318.762 Monoisotopic: 318.099586839 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
